Access to an extensive collection of clinically-annotated human specimens as well as collaborative project design and technical support for clinical studies.

Services

• Peer-reviewed access to a variety of deidentified, subject-derived biospecimens and metadata for research use.
• Comprehensive tissue tracking with support from the URMC Department of Pathology to ensure expeditious sample allocation without compromising patient care.
• Standardized preanalytical variable (ischemia times, processing details) and clinicopathologic data collection for all samples made accessible through the Biobank BLIS database.
• Study-specific collection support (enrollment, processing, storage) that includes several tissue processing options.
• Range of consultation services for clinical studies including RSRB compliance.

To register for access to the Biobank sample catalog, request a service, or for more information, please contact Bradley Mills, Biobank Director.

For additional information about equipment and services, see the Wilmot Biobank and Biospecimen Research Center.

Leadership

Bradley Mills, Ph.D.

NCI Designation and Acknowledging the CCSG

The National Cancer Institute (NCI) named the University of Rochester's Wilmot Cancer Institute as the nation's 73rd designated cancer center.  Publicizing the outcomes of NIH-funded projects and communicating the role of NIH support in biomedical research improves public understanding of how we, the biomedical research community as a whole, are working to improve human health.  To properly acknowledge the Cancer Center Support Grant (CCSG) in your work which utilized the Shared Resources since March 15th, 2025, please include the following statement in the acknowledgement section of your publication(s):

“The work described in this [publication | presentation | poster] benefited from the support of the [Biobank | Biostatistics and Bioinformatics | Cytometry | Genomics | Human Biophysiology | Imaging and Radiation | Metabolomics] Shared Resource[s] at the Wilmot Cancer Institute, supported in part by the University of Rochester Wilmot Cancer Institute Support Grant #P30CA272302. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."